Global Cardiac Biomarkers Testing Market to reach a market size of $16.2 billion by 2025 - KBV Research

Published Date: 01-06-2019

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Global Cardiac Biomarkers Testing Market, published by KBV research, The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.

The North America market dominated the Global Creatine Kinase (CK-MB) Market by Region in 2018, growing at a CAGR of 9.9 % during the forecast period. The Europe market is expected to witness a CAGR of 10.3% during (2019 - 2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 12% during (2019 - 2025).

The Myocardial Infarction market dominated the Global Cardiac Biomarkers Testing Market by Application in 2018, growing at a CAGR of 11 % during the forecast period. The Congestive Heart Failure market is expected to witness a CAGR of 12.5% during (2019 - 2025). Additionally, The Acute Coronary Syndrome market is expected to witness highest CAGR of 10.9% during (2019 - 2025).

The Laboratory Testing market dominated the Global Cardiac Biomarkers Testing Market by Location of Testing in 2018, growing at a CAGR of 10.3 % during the forecast period. The Point of Care Testing market is expected to witness highest CAGR of 13.6% during (2019 - 2025).

Full Report: https://www.kbvresearch.com/cardiac-biomarkers-testing-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Global Cardiac Biomarkers Testing Market Segmentation

By Type

  • Creatine Kinase (CK-MB)
  • Troponins
  • Myoglobin
  • Natriuretic Peptides (BNP and NT-proBNP)
  • Ischemia Modified Albumin
  • Others

By Application

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

By Location of Testing

  • Point of Care Testing
  • Laboratory Testing

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Cardiac Biomarkers Testing Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.